Explore 3 Stock Ideas & Industry Insights Download Free Report

8082-737-676
Shopping Cart 0
countryflagUK
Login

Home CompaniesMangoceuticals, Inc. Common Stock

Mangoceuticals, Inc. Common Stock

Healthcare Health Information Services
PortfolioPortfolio WatchlistWatchlist
Company price
0.197 USD 0.00 ( 1.03%)
Last update at 2026-11-09T17:39:00Z
VOLUME
35001
Market Cap
9.06M

Momentum Score

…

Mangoceuticals, Inc. engages in the development, marketing, and sale of various men's wellness products and services through a telemedicine platform in the United States. The company offers erectile dysfunction products under the Mango brand; hair loss products under the Grow brand; hormone balance and therapy products under the Mojo brand; and weight loss products under the Slim brand. It also provides oral testosterone undecanoate to treat low testosterone in men and as a form of testosterone replacement therapy under the Prime brand; and access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations. In addition, the company markets and sells its products online through its website www.MangoRX.com. The company was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. operates as a subsidiary of Cohen Enterprises, Inc.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.20
Low
0.21
High
52 Week Price Range
0.16
Low
2.75
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
0.20
Dividend Yield
-
Revenue TTM
0.32M
Revenue Per Share
0.02
Gross Profit TTM
0.17M
Debt / Equity
0.02
ROE
-95.10%
Net Debt
-1.18M
ROCE
-135.14%
Diluted EPS TTM
-1.04

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -20.64M -8.71M -9.21M -2.00M -
Minority interest 0.00M 0.00M 0.00M - -
Net income -20.64M -8.71M -9.21M -2.00M -
Selling general administrative 15.90M 6.42M 3.32M 2.00M -
Selling and marketing expenses 0.82M 1.48M 2.10M - -
Gross profit 0.25M 0.38M 0.43M 0.00M -
Reconciled depreciation 1.72M 0.73M 0.02M 0.00M -
Ebit -20.54M -8.68M -8.12M -1.99M -0.07M
Ebitda -18.82M -7.96M -8.09M -1.99M -
Depreciation and amortization 1.72M 0.72M 0.02M 0.00M -
Operating income -19.15M -7.97M -9.22M -1.99M -
Other operating expenses 19.61M 8.59M 9.95M 2.00M -
Interest expense 0.10M 0.01M 0.00M 0.01M -
Tax provision 0.00M 0.00M 0.00M 0.00M -
Net interest income -0.10M -0.01M 0.00M -0.01M -
Income tax expense - - 0.00M - -
Total revenue 0.46M 0.62M 0.73M 0.01M -
Total operating expenses 19.41M 8.35M 9.65M 2.00M -
Cost of revenue 0.21M 0.24M 0.30M 0.00M -
Total other income expense net -1.49M -0.73M 0.01M -0.01M -
Net income from continuing ops -20.64M -8.71M -7.32M -2.00M -
Net income applicable to common shares - - - -2.00M -0.07M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 16.09M 15.37M 1.05M 1.00M 0.02M
Intangible assets 14.23M 15.23M - - -
Other current assets 0.06M 0.02M 0.06M - -
Total liab 0.89M 1.43M 0.28M 0.39M 0.04M
Total stockholder equity 15.20M 13.95M 0.77M 0.61M -0.02M
Other current liab 0.17M 0.37M 0.01M 0.00M -
Common stock 0.00M 0.00M 0.00M 0.00M 0.00M
Capital stock 0.00M 0.00M 0.00M 0.00M 0.00M
Retained earnings -40.65M -20.81M -11.23M -2.02M -0.02M
Other assets - - - 0.02M -
Cash 1.49M 0.06M 0.74M 0.68M 0.02M
Total current liabilities 0.89M 1.43M 0.21M 0.26M 0.04M
Net debt -1.18M 0.16M -0.61M -0.33M 0.02M
Short term debt 0.31M 0.21M 0.06M 0.22M 0.04M
Short long term debt - 0.15M - 0.17M 0.04M
Short long term debt total 0.31M 0.21M 0.13M 0.35M 0.04M
Other stockholder equity 55.85M 34.76M 12.00M 2.63M 0.00M
Property plant equipment - - - 0.29M -
Total current assets 1.55M 0.08M 0.82M 0.69M 0.02M
Net tangible assets - - - 0.61M -0.02M
Net receivables - - 0.00M - -
Inventory - 0.00M 0.02M - -
Accounts payable 0.42M 0.84M 0.14M 0.03M -
Accumulated other comprehensive income -0.00M -0.01M - - -
Non currrent assets other - - 0.02M 0.02M -
Non current assets total 14.54M 15.29M 0.23M 0.31M 0.00M
Capital lease obligations 0.31M 0.06M 0.13M 0.19M -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments - 0.07M -0.04M -0.04M -
Change to liabilities - - - 0.03M 0.00M
Total cashflows from investing activities - 0.07M -0.00M -0.04M -0.04M
Net borrowings 0.47M 0.15M -0.17M 0.05M 0.16M
Total cash from financing activities 7.27M 4.13M 7.06M 2.05M 0.16M
Change to operating activities - - - -0.01M -0.01M
Net income -20.64M -8.71M -9.21M -2.00M -0.07M
Change in cash 1.43M -0.68M 0.06M 0.66M 0.09M
Begin period cash flow 0.06M 0.74M 0.68M 0.02M -
End period cash flow 1.49M 0.06M 0.74M 0.68M 0.02M
Total cash from operating activities -5.85M -4.86M -7.00M -1.35M -0.07M
Issuance of capital stock 4.73M 3.98M 5.50M 2.00M -
Depreciation 1.12M 0.73M 0.02M 0.00M 0.00M
Other cashflows from investing activities - 0.07M - - -
Dividends paid - 0.80M - - -
Change to inventory - 0.02M -0.02M - -
Change to account receivables -0.02M - 0.05M - -
Other cashflows from financing activities 1.15M 3.45M 1.02M 0.07M -
Change to netincome - - - 0.63M 0.00M
Capital expenditures 0.00M 0.00M 0.00M 0.04M 0.04M
Change in working capital 0.97M 0.66M 0.04M 0.02M -
Stock based compensation 1.17M 0.25M 0.62M 0.23M -
Other non cash items 11.53M 2.20M 1.52M 0.39M -
Free cash flow -5.85M -4.86M -7.00M -1.39M -

Peer Comparison*

Sector: Healthcare Industry: Health Information Services

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
MGRX
Mangoceuticals, Inc. Common Stock		 0.00
1.03%		 0.20 - - 28.74 0.71 28.35 -0.51
VEEV
Veeva Systems Inc Class A		 3.02
0.99%		 306.75 43.49 29.59 12.48 5.79 10.39 33.41
PMCUF
Pro Medicus Limited		 -
-%		 144.00 64.90 90.91 49.11 38.05 65.12 83.47
TEM
Tempus AI, Inc. Class A Common Stock		 7.28
9.57%		 83.33 - - 8.68 25.39 8.33 -
MTHRY
M3 Inc		 0.30
5.27%		 5.99 31.84 26.25 0.05 4.60 0.04 0.12

Profile*

Mangoceuticals, Inc. Common Stock

Mangoceuticals, Inc. engages in the development, marketing, and sale of various men's wellness products and services through a telemedicine platform in the United States. The company offers erectile dysfunction products under the Mango brand; hair loss products under the Grow brand; hormone balance and therapy products under the Mojo brand; and weight loss products under the Slim brand. It also provides oral testosterone undecanoate to treat low testosterone in men and as a form of testosterone replacement therapy under the Prime brand; and access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations. In addition, the company markets and sells its products online through its website www.MangoRX.com. The company was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. operates as a subsidiary of Cohen Enterprises, Inc.

17130 N. Dallas Parkway, Dallas, TX, United States, 75248

214 242 9619

https://www.mangoceuticals.com

3

Name Title Year Born
Mr. Jacob D. Cohen CEO & Chairman 1979
Mr. Eugene M. Johnston Chief Financial Officer 1964
Ms. Amanda Elizabeth Hammer Chief Operating Officer 1986
Mr. Jacob D. Cohen Co-Founder, CEO & Chairman 1979

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

DAR
GBX 8.30
+23.42%
VTY
GBX 276.20
+8.23%
GTCO
GBX 0.09
+6.98%
GLV
GBX 2.34
+6.36%
BUR
GBX 249.20
+5.95%
TMI
GBX 0.72
-6.49%
HSBA
GBX 1291.40
-5.42%
RKT
GBX 5218.00
-4.85%
TGA
GBX 643.00
-4.03%
RKH
GBX 61.70
-3.89%

Equity Sectors*

  • Basic Materials

    -1.70%

  • Communication Services

    +0.33%

  • Consumer Cyclical

    +0.45%

  • Consumer Defensive

    -0.56%

  • Energy

    -0.25%

  • Financial Services

    +0.49%

  • Healthcare

    +0.20%

  • Industrials

    +0.74%

  • Real Estate

    +1.71%

  • Technology

    -2.81%

  • Utilities

    +0.28%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Cookies on this website

We use some essential cookies to make this site work. We also set analytics and marketing cookies, described below, to understand how you use the site and to measure our advertising. For more detailed information, see our Cookie Policy, Privacy Policy and Terms and Conditions.

Essential cookies

These cookies are necessary for core functionality, such as security, your shopping cart, remembering your cookie choice, and your progress through a report or free-trial request you started. They always need to be on.

Analytics cookies

We use analytics cookies to understand how visitors use the site — the pages visited, time spent, and where visitors came from.

Marketing cookies

These help us measure how effective our advertising is, such as recording actions you take after clicking one of our ads. If you don't enable this, you may still see our ads, but they won't be measured this way.

Support

Hi! How can we help you today?

Loading…